EC Number   |
Expression |
Reference |
|---|
    2.3.3.1 | down |
acute administration of olanzapine inhibits citrate synthase activity in cerebellum and prefrontal cortex |
720554 |
| 2.3.3.1 | down |
during sexual development, the expression of citrate synthase is significantly weak in the content of cleistothecia including ascospores |
-, 720215 |
| 2.3.3.1 | down |
the mRNA expression of citrate synthase in liver is reduced by 42% in the staggerer mice (which possess a nonfunctional retinoic acid receptor-related orphan receptor alpha protein) relative to the wild type mice |
720857 |
| 2.3.3.1 | more |
expression is regulated by catabolite control protein C (CcpC) |
704320 |
| 2.3.3.1 | up |
Al3+ increases the expression level of citrate synthase gene and enzyme activity |
706384 |
| 2.3.3.1 | up |
AlCl3 treatment |
705651 |
| 2.3.3.1 | up |
during sexual development, the expression of citrate synthase is quite strong in cleistothecial shells. Acetate shows a strong inductive effect on citA expression, which is subjected to carbon catabolite repression caused by glucose |
-, 720215 |
| 2.3.3.1 | up |
in AlCl3 containing growth edium |
703601 |
| 2.3.3.1 | up |
oanzapine 3 mg/kg and fluoxetine 12.5 mg/kg in combination increase citrate synthase activity in prefrontal cortex, hippocampus and striatum. The chronic administration of olanzapine increases citrate synthase activity in prefrontal cortex, hippocampus and striatum and fluoxetine increases citrate synthase activity in striatum |
720554 |
| 2.3.3.1 | up |
overexpression of retinoic acid receptor-related orphan receptor alpha (5fold), leads to a 94% increase in citrate synthase mRNA levels and enzyme activity in Hep-G2 cells |
720857 |
